A Novel Inflammatory and Nutritional Prognostic Scoring System for Nonpathological Complete Response Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Figure 5

Kaplan-Meier curves of different HER-2 status breast cancer patients for OS (a) DFS (b). K-M analysis of OS (c) and DFS (d) for HER-2 negative breast cancer patients by INPS; K-M analysis of OS (e) and DFS (f) for HER-2 low expression breast cancer patients by INPS; K-M analysis of OS (g) and DFS (h) for HER-2 positive breast cancer patients by INPS.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)